Dopamine and serotonin release in dorsal striatum and nucleus accumbens is differentially modulated by morphine in DBA/2J and C57BL/6J mice-Reference-Cited by-同舟云学术

Dopamine and serotonin release in dorsal striatum and nucleus accumbens is differentially modulated by morphine in DBA/2J and C57BL/6J mice

Published:2005 Issue:1 Volume:56 Page:29-38
ISSN:0887-4476
Container-title:Synapse
language:en
Short-container-title:Synapse

Author:

Fadda Paola,Scherma Maria,Fresu Alessandra,Collu Maria,Fratta Walter

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience

Reference60 articles.

1. Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens

2. Retardation of cerebral dopamine turnover after morphine withdrawal and its enhanced acceleration by acute morphine administration in rats

3. 1978. Morphine-induced behavior of mice and its relation to brain catecholamines. In: editors. Characteristics and function of opioids. Elsevier: North-Holland Biomedical Press. p 349-350.

4. Time-dose relationships for locomotor activity effects of morphine after acute or repeated treatment

5. 1991. Studies of genetic differences in response to opioid drugs. In: editors. The genetic basis of alcohol and drug actions. New York: Plenum Press. p 225-252.

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resolution of tonic concentrations of highly similar neurotransmitters using voltammetry and deep learning;Molecular Psychiatry;2024-04-25

2. HIV‐1 Tat and morphine interactions dynamically shift striatal monoamine levels and exploratory behaviors over time;Journal of Neurochemistry;2024-02-03

3. Mu Opioid Receptor–Expressing Neurons in the Dorsal Raphe Nucleus Are Involved in Reward Processing and Affective Behaviors;Biological Psychiatry;2023-12

4. Contribution of the opioid system to depression and to the therapeutic effects of classical antidepressants and ketamine;Life Sciences;2023-08

5. Role of the mesolimbic dopamine pathway in the antidepressant effects of ketamine;Neuropharmacology;2023-03